Experiment 1087471
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Empty organism |
| Citation | JACKSON JR,RV: SETHI,VS: SPURR,CL: WILLARD,V: WHITE,DR: RICHARDS II,F: STUART,JJ: MUSS,HB: COOPER,MR: HOMESLEY,HD: JOBSON,VW: CASTLE,MC:. (1981). INTRAVENOUS VINCRISTINE INFUSION. PHASE I TRIAL.. 48() |
| Amount utilized | |
| Compound isolated | |
| Disease | PHASE I CLINICAL TRIAL WITH 30 PATIENTS WITH REFRACTORY MALIGNANCIES. 11/30 PATIENTS RESPONDED. COMPLETE REMISIONS IN 3 PATIENTS. PHASE I CLINICAL TRIAL WITH 30 PATIENTS WITH REFRACTORY MALIGNANCIES. 11/30 PATIENTS RESPONDED. COMPLETE REMISIONS IN 3 PATIENTS. PHASE I CLINICAL TRIAL WITH 30 PATIENTS WITH REFRACTORY MALIGNANCIES. 11/30 PATIENTS RESPONDED. COMPLETE REMISIONS IN 3 PATIENTS. PHASE I CLINICAL TRIAL WITH 30 PATIENTS WITH REFRACTORY MALIGNANCIES. 11/30 PATIENTS RESPONDED. COMPLETE REMISIONS IN 3 PATIENTS. PHASE I CLINICAL TRIAL WITH 30 PATIENTS WITH REFRACTORY MALIGNANCIES. 11/30 PATIENTS RESPONDED. COMPLETE REMISIONS IN 3 PATIENTS. PHASE I CLINICAL TRIAL WITH 30 PATIENTS WITH REFRACTORY MALIGNANCIES. 11/30 PATIENTS RESPONDED. COMPLETE REMISIONS IN 3 PATIENTS. |
| Dose amount | 0.75 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |